Microcirculation in sepsis: New perspectives

Current Vascular Pharmacology

Volumn 11, Issue 2, 2013, Pages 161-169

  Hernandez, Glenn ^a,b   Bruhn, Alejandro ^b   Ince, Can ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Fluids; Lactate; Microcirculation; OPS SDF imaging; Sepsis; Septic shock; Vasoactive drugs

Indexed keywords

ACTIVATED PROTEIN C; DOBUTAMINE; GLYCERYL TRINITRATE; HETASTARCH; HYDROCORTISONE; HYPERTENSIVE FACTOR; LEVOSIMENDAN; NITRIC OXIDE; NORADRENALIN; VASOCONSTRICTOR AGENT;

BLOOD FLOW; BLOOD OXYGEN TENSION; CLINICAL TRIAL (TOPIC); ERYTHROCYTE TRANSFUSION; FLUID RESUSCITATION; HEMOFILTRATION; HUMAN; HYPOXEMIA; ISCHEMIA; MEAN ARTERIAL PRESSURE; MICROCIRCULATION; MICROVASCULATURE; NONHUMAN; OXYGEN TRANSPORT; PERFUSION; REVIEW; SEPSIS; SEPTIC SHOCK; ANIMAL; DRUG EFFECTS; HEMODYNAMICS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; TRENDS; VIDEO MICROSCOPY;

ANIMALS; HEMODYNAMICS; HUMANS; MICROCIRCULATION; MICROSCOPY, VIDEO; SEPSIS; SEVERITY OF ILLNESS INDEX; VASOCONSTRICTOR AGENTS;

EID: 84875362828     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/1570161111311020006     Document Type: Review

References (70)

1. Ince C. The microcirculation is the motor of sepsis. Crit Care (London, England). 2005;9 (Suppl 4):S13-19.
2. Vallet B. Endothelial cell dysfunction and abnormal tissue perfusion. Crit Care Med 2002;30(5 Suppl):S229-234.
3. Verdant C, De Backer D. How monitoring of the microcirculation may help us at the bedside. Curr Opin Crit Care 2005;11(3):240-244.
4. Klijn E, Den Uil CA, Bakker J, Ince C. The heterogeneity of the microcirculation in critical illness. Clin Chest Med 2008;29(4):643-654, viii.
5. Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999;27(7):1369-1377.
6. De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002;166(1):98-104.
7. Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: Relationship to hemodynamics, oxygen transport, and survival. Anna Emerg Med 2007;49(1):88-98, 98 e81-82.
8. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004;32(9):1825-1831.
9. Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: Microvascular dysfunction in sepsis--hemodynamics, oxygen transport, and nitric oxide. Crit Care (London, Eng). 2003;7(5):359-373.
10. Spronk PE, Zandstra DF, Ince C. Bench-to-bedside review: Sepsis is a disease of the microcirculation. Crit Care (London, Eng). 2004;8(6):462-468.
11. Ait-Oufella H, Maury E, Lehoux S, Guidet B, Offenstadt G. The endothelium: Physiological functions and role in microcirculatory failure during severe sepsis. Intensive Care Med 2010;36(8):1286-1298.
12. Ellis CG, Jagger J, Sharpe M. The microcirculation as a functional system. Crit Care (London, Eng). 2005;9 (Suppl 4):S3-8.
13. Sherman H, Klausner S, Cook WA. Incident dark-field illumination: A new method for microcirculatory study. Angiology 1971;22(5):295-303.
14. Slaaf DW, Tangelder GJ, Reneman RS, Jager K, Bollinger A. A versatile incident illuminator for intravital microscopy. Int J Microcirc Clin Exp 1987;6(4):391-397.
15. Goedhart PT, Khalilzada M, Bezemer R, Merza J, Ince C. Sidestream dark field (sdf) imaging: A novel stroboscopic led ringbased imaging modality for clinical assessment of the microcirculation. Opt Express 2007;15(23):15101-15114.
16. Groner W, Winkelman JW, Harris AG, et al. Orthogonal polarization spectral imaging: A new method for study of the microcirculation. Nat Med 1999;5(10):1209-1212.
17. Cerny V, Turek Z, Parizkova R. Orthogonal polarization spectral imaging. Physiol Res 2007;56(2):141-147.
18. De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: Report of a round table conference. Crit Care (London, Eng) 2007;11(5):R101.
19. Bezemer R, Dobbe JG, Bartels SA, et al. Rapid automatic assessment of microvascular density in sidestream dark field images. Med Biol Eng Comput 2011;49(11):1269-1278.
20. Boerma EC, van der Voort PH, Spronk PE, Ince C. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Crit Care Med 2007;35(4):1055-1060.
21. Verdant CL, De Backer D, Bruhn A, et al. Evaluation of sublingual and gut mucosal microcirculation in sepsis: A quantitative analysis. Crit Care Med 2009;37(11):2875-2881.
22. Knotzer H, Hasibeder WR. Microcirculatory function monitoring at the bedside--a view from the intensive care. Physiol Meas 2007;28(9):R65-86.
23. Boerma EC, Koopmans M, Konijn A, et al. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: A doubleblind randomized placebo controlled trial. Crit Care Med 201027;38(1):93-100.
24. Dubin A, Pozo MO, Casabella CA, et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010;25(4):659 e651-658.
25. Morelli A, Donati A, Ertmer C, et al. Levosimendan for resuscitating the microcirculation in patients with septic shock: A randomized controlled study. Crit Care (London, Eng). 2010;14(6):R232.
26. Pottecher J, Deruddre S, Teboul JL, et al. Both passive leg raising and intravascular volume expansion improve sublingual microcirculatory perfusion in severe sepsis and septic shock patients. Intensive Care Med 2010;36(11):1867-1874.
27. Ruiz C, Hernandez G, Godoy C, Downey P, Andresen M, Bruhn A. Sublingual microcirculatory changes during high-volume hemofiltration in hyperdynamic septic shock patients. Crit Care (London, Eng) 2010;14(5):R170.
28. Boerma EC, Kuiper MA, Kingma WP, Egbers PH, Gerritsen RT, Ince C. Disparity between skin perfusion and sublingual microcirculatory alterations in severe sepsis and septic shock: A prospective observational study. Intensive Care Med 2008;34(7): 1294-1298.
29. De Backer D, Creteur J, Dubois MJ, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006;34(2):403-408.
30. Spanos A, Jhanji S, Vivian-Smith A, Harris T, Pearse RM. Early microvascular changes in sepsis and severe sepsis. Shock 2010;33(4):387-391.
31. Trzeciak S, McCoy JV, Phillip Dellinger R, et al. Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008;34(12):2210-2217.
32. Hernandez G, Castro R, Romero C, et al. Persistent sepsis-induced hypotension without hyperlactatemia: Is it really septic shock? J Crit Care 2011;26(4):435 e439-414.
33. Farquhar I, Martin CM, Lam C, Potter R, Ellis CG, Sibbald WJ. Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996;15;61(1):190-196.
34. Goldman D, Bateman RM, Ellis CG. Effect of decreased o2 supply on skeletal muscle oxygenation and o2 consumption during sepsis: Role of heterogeneous capillary spacing and blood flow. Am J Physiol 2006;290(6):H2277-2285.
35. Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactateguided therapy in intensive care unit patients: A multicenter, openlabel, randomized controlled trial. Am J Resp Crit Care Med 2010;15;182(6):752-761.
36. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. Eng J Med 2001;8;345(19):1368-1377.
37. Textoris J, Fouche L, Wiramus S, et al. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Criti Care (London, Eng) 2011; 26;15(4):R176.
38. Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Med 2010;36(6):949-955.
39. Allison KP, Gosling P, Jones S, Pallister I, Porter KM. Randomized trial of hydroxyethyl starch versus gelatine for trauma resuscitation. J Trauma 1999;47(6):1114-1121.
40. Ondiveeran HK, Fox-Robichaud AE. Pentastarch in a balanced solution reduces hepatic leukocyte recruitment in early sepsis. Microcirculation 2004;11(8):679-687.
41. Kupper S, Mees ST, Gassmann P, Brodde MF, Kehrel B, Haier J. Hydroxyethyl starch normalizes platelet and leukocyte adhesion within pulmonary microcirculation during lps-induced endotoxemia. Shock 2007;28(3):300-308.
42. Neff TA, Fischler L, Mark M, Stocker R, Reinhart WH. The influence of two different hydroxyethyl starch solutions (6% hes 130/0.4 and 200/0.5) on blood viscosity. Anesth Analg 2005;100(6):1773-1780.
43. Zakaria el R, Li N, Matheson PJ, Garrison RN. Cellular edema regulates tissue capillary perfusion after hemorrhage resuscitation. Surgery 2007;142(4):487-496; discussion 496 e481-482.
44. Harrois A, Dupic L, Duranteau J. Targeting the microcirculation in resuscitation of acutely unwell patients. Curr Opin Crit Care 2011;17(3):303-307.
45. Sakr Y, Chierego M, Piagnerelli M, et al. Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med 2007;35(7):1639-1644.
46. Creteur J, Neves AP, Vincent JL. Near-infrared spectroscopy technique to evaluate the effects of red blood cell transfusion on tissue oxygenation. Crit Care (London, Eng) 2009;13 (Suppl 5):S11.
47. Genzel-Boroviczeny O, Christ F, Glas V. Blood transfusion increases functional capillary density in the skin of anemic preterm infants. Pediatr Res 2004;56(5):751-755.
48. Yuruk K, Bartels SA, Milstein DM, Bezemer R, Biemond BJ, Ince C. Red blood cell transfusions and tissue oxygenation in anemic hematology outpatients. Transfusion 2012;52(3): 641-6.
49. Yuruk K, Almac E, Bezemer R, Goedhart P, de Mol B, Ince C. Blood transfusions recruit the microcirculation during cardiac surgery. Transfusion 2011;51(5):961-967.
50. Georger JF, Hamzaoui O, Chaari A, Maizel J, Richard C, Teboul JL. Restoring arterial pressure with norepinephrine improves muscle tissue oxygenation assessed by near-infrared spectroscopy in severely hypotensive septic patients. Intensive care medicine. 2010;36(11):1882-1889.
51. Boerma EC, Ince C. The role of vasoactive agents in the resuscitation of microvascular perfusion and tissue oxygenation in critically ill patients. Intens Care Med 2010;36(12):2004-2018.
52. Jhanji S, Stirling S, Patel N, Hinds CJ, Pearse RM. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med 2009;37(6):1961-1966.
53. Dubin A, Pozo MO, Casabella CA, et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: A prospective study. Crit Care (London, Eng). 2009;13(3):R92.
54. Buwalda M, Ince C. Opening the microcirculation: Can vasodilators be useful in sepsis? Intensive Care Med 2002;28(9):1208-1217.
55. Trzeciak S, Cinel I, Phillip Dellinger R, et al. Resuscitating the microcirculation in sepsis: The central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008;15(5):399-413.
56. Taylor AE, Moore TM. Capillary fluid exchange. Am J Physiol 1999;277(6 Pt 2):S203-210.
57. Spronk PE, Ince C, Gardien MJ, Mathura KR, Oudemans-van Straaten HM, Zandstra DF. Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002 2;360(9343):1395-1396.
58. Dubin A, Murias G, Sottile JP, et al. Effects of levosimendan and dobutamine in experimental acute endotoxemia: A preliminary controlled study. Intensive Care Med 2007;33(3):485-494.
59. Morelli A, Ertmer C, Lange M, et al. Effects of short-term simultaneous infusion of dobutamine and terlipressin in patients with septic shock: The dobupress study. Brit J Anaesthesia 2008;100(4):494-503.
60. Levi M, van der Poll T, ten Cate H, van Deventer SJ. The cytokinemediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. Eur J Clin Invest 1997;27(1):3-9.
61. Joyce DE, Nelson DR, Grinnell BW. Leukocyte and endothelial cell interactions in sepsis: Relevance of the protein c pathway. Crit Care Med 2004;32(5 Suppl):S280-286.
62. Lehmann C, Meissner K, Knock A, et al. Activated protein c improves intestinal microcirculation in experimental endotoxaemia in the rat. Crit Care (London, Eng). 2006;10(6):R157.
63. Iba T, Kidokoro A, Fukunaga M, Nagakari K, Shirahama A, Ida Y. Activated protein c improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in a rat lipopolysaccharide model. Crit Care Med 2005;33(2):368-372.
64. Marechal X, Favory R, Joulin O, et al. Endothelial glycocalyx damage during endotoxemia coincides with microcirculatory dysfunction and vascular oxidative stress. Shock 2008;29(5):572-576.
65. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein c for severe sepsis. N Eng J Med 2001 8;344(10):699-709.
66. De Backer D, Verdant C, Chierego M, Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006;34(7):1918-1924.
67. De Backer D, Donadello K, Taccone FS, Ospina-Tascon G, Salgado D, Vincent JL. Microcirculatory alterations: Potential mechanisms and implications for therapy. Ann Intens Care 2011;1(1):27.
68. Buchele GL, Silva E, Ospina-Tascon GA, Vincent JL, De Backer D. Effects of hydrocortisone on microcirculatory alterations in patients with septic shock. Crit Care Med 2009;37(4):1341-1347.
69. Cornejo R, Downey P, Castro R, et al. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 2006;32(5):713-722.
70. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28(11):3581-3587.